Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 05, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The material change reported is a transfer of 40,662 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on January 3, 2007, and the company was advised of it on January 5, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(b). The GSK Trust is identified as a discretionary trust where all employees or former employees are potential beneficiaries.
Key Facts for Investor Verification
- Transaction Date: January 3, 2007.
- Shares Transferred: 40,662 Ordinary Shares.
- Source: GlaxoSmithKline Employee Trust.
- Destination: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Directors with potential interest in the trust: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop.